戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ohorts because of inclusion of children with craniopharyngioma.
2 roup study involving patients with papillary craniopharyngiomas, 15 of 16 patients had a partial resp
3 ), medulloblastoma (22), ganglioglioma (18), craniopharyngioma (16), and atypical teratoid rhabdoid t
4  (resulting in p.Val600Glu) in all papillary craniopharyngiomas (3/3, 100%).
5 evealed BRAF p.Val600Glu in 95% of papillary craniopharyngiomas (36 of 39 tumors) and mutation of CTN
6 utation of CTNNB1 in 96% of adamantinomatous craniopharyngiomas (51 of 53 tumors).
7  in patients with an underlying diagnosis of craniopharyngioma (9.28 [5.84-14.75] vs 1.61 [1.30-1.99]
8  two histological subtypes, adamantinomatous craniopharyngioma (ACP) and papillary craniopharyngioma
9 of tumours resembling human adamantinomatous craniopharyngioma (ACP), derived from Sox2- cells in a p
10  the pediatric brain tumor, adamantinomatous craniopharyngioma (ACP).
11 of hypopituitarism, hypothalamic obesity, or craniopharyngioma and NAFLD was undertaken.
12 diagnosed in a 10-year period, excluding all craniopharyngioma and pituitary tumors.
13 tified age at diagnosis, sex, a diagnosis of craniopharyngioma, and untreated gonadotropin deficiency
14 ents had non-functioning adenomas, 118 (12%) craniopharyngiomas, and 93 (9%) prolactinomas.
15                                              Craniopharyngiomas are epithelial tumors that typically
16                                              Craniopharyngiomas are rare malformational tumours of lo
17 his single-arm, phase 2 study, patients with craniopharyngioma at St Jude Children's Research Hospita
18 ng has shown that more than 90% of papillary craniopharyngiomas carry BRAF V600E mutations, but data
19 s in paediatric and adolescent patients with craniopharyngioma compared with a historical cohort, and
20 or localized primary brain tumors, including craniopharyngioma, ependymoma, and juvenile pilocytic as
21 beta-catenin) in nearly all adamantinomatous craniopharyngiomas examined (11/12, 92%) and recurrent m
22 re, non-cancerous parasellar masses, such as craniopharyngiomas, germ cell tumours, gliomas, cysts of
23               Adamantinomatous and papillary craniopharyngiomas harbor mutations that are mutually ex
24 lls that eventually develop into a papillary craniopharyngioma-like tumor.
25 bal attention disorders were associated with craniopharyngioma (P < .0001), supratentorial tumors (P
26            Finally, we reveal that papillary craniopharyngioma (PCP), a benign human pituitary tumour
27 matous craniopharyngioma (ACP) and papillary craniopharyngioma (PCP), differ in genesis and age distr
28          Irradiated primary lesions included craniopharyngioma, pituitary adenoma, Hodgkin's lymphoma
29                                              Craniopharyngiomas, primary brain tumors of the pituitar
30 igh concentration of proteins (colloid cyst, craniopharyngioma, Rathke's cleft cyst, ectopic posterio
31          Eligible patients who had papillary craniopharyngiomas that tested positive for BRAF mutatio
32  for paediatric and adolescent patients with craniopharyngioma treated with limited surgery and proto
33         Children and adolescents treated for craniopharyngioma using limited surgery and post-operati
34 Age at diagnosis, female sex, and above all, craniopharyngioma were significant independent risk fact
35 sure of normal brain tissue in patients with craniopharyngioma, which might reduce cognitive deficits
36 AF-MEK inhibition in patients with papillary craniopharyngiomas who have not undergone previous radia